Topics

Long-Stalled Legislation Aimed At Increasing Competition From Cheaper Generic Drugs To Finally Move Forward

08:49 EDT 4 Apr 2019 | Kaiser Health News

House Energy and Commerce Committee Chairman Frank Pallone Jr. (D-N.J.) and Rep. Greg Walden (R-Ore.) have reached a key agreement over the measure. Aides in both parties said Democrats verbally agreed to make changes to one of the most prominent measures, known as the Creates Act, which cracks down on tactics drug companies use to delay the introduction of cheaper generic drugs.

Original Article: Long-Stalled Legislation Aimed At Increasing Competition From Cheaper Generic Drugs To Finally Move Forward

NEXT ARTICLE

More From BioPortfolio on "Long-Stalled Legislation Aimed At Increasing Competition From Cheaper Generic Drugs To Finally Move Forward"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...